This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of active pharmaceutical ingredients (APIs) for therapeutic applications. It serves as a key building block in the preparation of compounds targeting specific biological pathways, such as enzyme inhibition or receptor modulation. Its structure, featuring a tert-butoxycarbonyl (Boc) protecting group and a dichlorophenyl moiety, makes it valuable in peptide synthesis and medicinal chemistry research. The compound is often employed in the creation of drug candidates for conditions like inflammation, central nervous system disorders, or infectious diseases, where precise molecular design is critical for efficacy and selectivity. Additionally, its chiral nature allows for the development of enantiomerically pure drugs, enhancing therapeutic outcomes and reducing side effects.